Chalmers JD, Burgel PR, Daley CL, DE-Soyza A, et al. TEMPORARY REMOVAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BRENSOCATIB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS - THE ASPEN TRIAL. Chest 2024;166.
PMID: 39362727